Gabriel, E., Attwood, K., Du, W., Tuttle, R., Alnaji, R. M., Nurkin, S., . . . Kukar, M. (2016). Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. JAMA Surg.
Citación estilo ChicagoGabriel, Emmanuel, Kristopher Attwood, William Du, Rebecca Tuttle, Raed M. Alnaji, Steven Nurkin, Usha Malhotra, Steven N. Hochwald, and Moshim Kukar. "Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation." JAMA Surg 2016.
Cita MLAGabriel, Emmanuel, et al. "Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation." JAMA Surg 2016.